| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ISHARES TR | 200,000 | 73,794,000 | 8.86% | Put | |
| 2 | SELECT SECTOR SPDR TR SBI HEALTHCARE | 700,000 | 52,073,000 | 6.25% | Put | |
| 3 | UNITEDHEALTH GROUP INC | 231,000 | 28,182,000 | 3.38% | ||
| 4 | ALEXION PHARMACEUTIC | 132,800 | 24,006,000 | 2.88% | ||
| 5 | ALKERMES PLC SHS | 349,000 | 22,455,000 | 2.70% | ||
| 6 | BIOGEN INC | 50,291 | 20,315,000 | 2.44% | ||
| 7 | CVS HEALTH CORP | 184,000 | 19,298,000 | 2.32% | ||
| 8 | JOHNSON & JOHNSON | 191,000 | 18,615,000 | 2.24% | ||
| 9 | CARDINAL HEALTH INC | 215,000 | 17,985,000 | 2.16% | ||
| 10 | CELGENE CORP | 137,000 | 15,856,000 | 1.90% | ||
| 11 | ABBVIE INC | 233,000 | 15,655,000 | 1.88% | ||
| 12 | GILEAD SCIENCES INC | 130,000 | 15,220,000 | 1.83% | ||
| 13 | RITE AID CORP | 1,817,000 | 15,172,000 | 1.82% | ||
| 14 | MERCK & CO INC | 260,000 | 14,802,000 | 1.78% | ||
| 15 | LILLY ELI & CO | 175,000 | 14,611,000 | 1.75% | ||
| 16 | BRISTOL MYERS SQUIBB CO | 198,000 | 13,175,000 | 1.58% | ||
| 17 | ALLERGAN PLC | 42,000 | 12,745,000 | 1.53% | ||
| 18 | BIOMARIN | 92,000 | 12,584,000 | 1.51% | ||
| 19 | JAZZ PHARMACEUTICALS PLC SHS USD | 70,000 | 12,325,000 | 1.48% | ||
| 20 | NEKTAR THERAPEUTICS COM | 937,000 | 11,722,000 | 1.41% | ||
| 21 | MEDTRONIC PLC | 154,800 | 11,471,000 | 1.38% | ||
| 22 | INCYTE | 107,502 | 11,203,000 | 1.35% | ||
| 23 | AMGEN INC | 69,000 | 10,593,000 | 1.27% | ||
| 24 | REGENERON PHARMACEUTICALS | 19,000 | 9,692,000 | 1.16% | ||
| 25 | CEMPRA INC | 277,161 | 9,523,000 | 1.14% | ||
| 26 | ANTHEM INC | 58,000 | 9,520,000 | 1.14% | ||
| 27 | UNIVERSAL HLTH SVCS INC | 65,000 | 9,237,000 | 1.11% | ||
| 28 | Esperion Therapeutics Inc | 112,000 | 9,157,000 | 1.10% | ||
| 29 | PERRIGO CO PLC | 47,000 | 8,687,000 | 1.04% | ||
| 30 | BECTON DICKINSON & CO | 60,000 | 8,499,000 | 1.02% | ||
| 31 | LABORATORY CORP AMER HLDGS | 70,000 | 8,485,000 | 1.02% | ||
| 32 | ACADIA PHARMACEUTICALS INC COM | 191,000 | 7,999,000 | 0.96% | ||
| 33 | ALNYLAM PHARMACEUTICALS INC | 61,400 | 7,360,000 | 0.88% | ||
| 34 | DEXCOM | 92,000 | 7,358,000 | 0.88% | ||
| 35 | COOPER COS INC | 41,000 | 7,297,000 | 0.88% | ||
| 36 | VALEANT PHARMACEUTICALS INTL | 32,248 | 7,164,000 | 0.86% | ||
| 37 | SUPERNUS PHARMACEUTICALS INC COM | 417,000 | 7,081,000 | 0.85% | ||
| 38 | EXPRESS SCRIPTS HLDG CO | 79,000 | 7,026,000 | 0.84% | ||
| 39 | COMMUNITY HEALTH SYS INC NEW COM | 110,000 | 6,927,000 | 0.83% | ||
| 40 | ABIOMED INC | 104,000 | 6,836,000 | 0.82% | ||
| 41 | VERTEX PHARMACEUT | 55,000 | 6,791,000 | 0.82% | ||
| 42 | INTRA CELLULAR THERAPIES INC COM | 206,000 | 6,582,000 | 0.79% | ||
| 43 | AETNA INC NEW | 51,000 | 6,500,000 | 0.78% | ||
| 44 | HCA HOLDINGS INC | 69,000 | 6,260,000 | 0.75% | ||
| 45 | ST JUDE | 83,000 | 6,065,000 | 0.73% | ||
| 46 | LIVANOVA PLC | 100,000 | 5,946,000 | 0.71% | ||
| 47 | INTERCEPT PHARMACEUTICAL | 24,000 | 5,793,000 | 0.70% | ||
| 48 | CERNER CORP | 83,000 | 5,732,000 | 0.69% | ||
| 49 | MYLAN N V | 83,000 | 5,632,000 | 0.68% | ||
| 50 | MCKESSON CORP | 25,000 | 5,620,000 | 0.67% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001415889-15-002492, filed 2015.07.30).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
